LYSARC (Lymphoma Studies Academic Research Company) was founded in 2012 following the merger of two leading academic groups (GELA and GOELAMS) who decided to combine their clinical experience, methodological expertise and access to patients. This merger created a world-class specialist research organization in the field of lymphoma. LYSARC objective is to improve the access of innovative therapies for lymphoma patients. LYSARC is a nonprofit trust governed by an independent Board composed of leading clinicians and pathologists with international reputation in the field of lymphoma research. For each trial, you will find the acronym, title of trial, population, trials details, inclusion and exclusion criteria.
Read more
Loading...

Additional Information

Updated
October 25, 2016
Size
6.2M
Installs
100+
Current Version
1.0.2
Requires Android
2.3 and up
Content Rating
Everyone
Permissions
Offered By
Haematology Clinical Research Network NSW
©2018 GoogleSite Terms of ServicePrivacyDevelopersArtistsAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.